Clémentine Fronteau

Home administration of bortezomib in multiple myeloma is cost-effective and is preferred by patients compared with hospital administration: results of a prospective single-center study

A. Lassalle, P. Thomaré, Clémentine Fronteau et al. · Annals of Oncology · 2015 · 45 citations

Home Administration, Hematological Malignancy, Oncology +7

Prophylactic or Preemptive Low-Dose Azacitidine and Donor Lymphocyte Infusion to Prevent Disease Relapse following Allogeneic Transplantation in Patients with High-Risk Acute Myelogenous Leukemia or Myelodysplastic Syndrome

Thierry Guillaume, Sylvain Thépot, Pierre Péterlin et al. · Transplantation and Cellular Therapy · 2021 · 43 citations · Full text

Transplantation Medicine, Immunology, Immunotherapy +16

Exploring the factors influencing adherence to oral anticancer drugs in patients with digestive cancer: a qualitative study

Pierre Nizet, Yann Touchefeu, Solange Pécout et al. · Supportive Care in Cancer · 2021 · 32 citations · Full text

Chemotherapy efficacy after first-line immunotherapy in 18 advanced melanoma patients

M. Saint‐Jean, Clémentine Fronteau, L. Peuvrel et al. · Medicine · 2020 · 21 citations · Full text

Tumor Immunology, Cancer Immunosurveillance, Immune Checkpoint Blockers +14

SMABcare study: subcutaneous monoclonal antibody in cancer care: cost-consequence analysis of subcutaneous rituximab in patients with follicular lymphoma

Emilie Fargier, Florence Ranchon, Laure Huot et al. · Annals of Hematology · 2017 · 18 citations

Lymphoid Neoplasia, Subcutaneous Monoclonal Antibody, Medicine +8